InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: linhdtu post# 16501

Friday, 10/11/2013 10:48:39 PM

Friday, October 11, 2013 10:48:39 PM

Post# of 426487
If FDA reject ANCHOR, does it mean it's OK not to treat patients with TG of say 350 or 450? The existing treatment options such as Lovaza, fibrates or Niacin just not getting the job done (with various side effects, etc.). Or FDA would rather encourage patients to get an off-lable script?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News